Konrad Schäfers

Advanced World Transport BV provides rail freight services. Its services include rail transport, rail sidings operation, intermodal transport, rail forwarding, freight wagon rental, and reclamation and groundworks. The company was founded in 2010 and is headquartered in Amsterdam, the Netherlands.

Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA.

Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain.

Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland.

Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022.

Corlieve Therapeutics SAS provides neurology services. The company was founded by Richard Porter, Valerie Crepel and Christophe Mulle in November 2019 and is headquartered in Paris, France.

ReWind Therapeutics NV is a biotech company based in Leuven, Belgium that develops first-in-class remyelinating therapies for myelin-related diseases. The Belgian company's aim is to bring these therapies into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged, leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition, and movement, among others. ReWind Therapeutics develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from major debilitating diseases such as multiple sclerosis, optic neuritis, or nerve injuries. The company's team has extensive R&D expertise and has built a strong patent estate for developing novel remyelination therapeutics. The company was founded in 2017 by Ku Leuven's Centre for Drug Design and Discovery (CD3) and Axxam S.p.A. The CEO of the company since 2021 is Anja Harmeier.

Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom.

Zanui Holding GmbH provides online shopping services. The private company is based in Berlin, Germany. The CEOs of the German company are Gregor Bernd Janknecht, Arnd Lodowicks.

Rocket Internet is the venture capital division of Rocket Internet SE founded in 2007 by the Samwer brothers Marc, Alexander, and Oliver. The firm is headquartered in Berlin, Germany.

Juwel 168. V V UG (haftungsbeschränkt) is a private company based in Berlin, Germany. The German company provides economic services. The CEO of the company is Arnt Jeschke.

Roche Ventures is the venture investment division of the pharmaceutical company F. Hoffmann-La Roche Ltd., which is a subsidiary of Roche Holding AG (SWX:ROG). The group is headquartered in Basel with operations and affiliates worldwide, and is a world leader in pharmaceuticals and diagnostics. The firm was founded in 2002.

Part of Giesecke+Devrient GmbH, Secartis AG is a German company that provides secure internal and external electronic business processes. The company is based in Grasbrunn, Germany. Secartis was acquired by secunet Security Networks AG, a PUB of Giesecke+Devrient GmbH from Giesecke+Devrient GmbH on February 02, 2004.

PwC Strategy& (Germany) GmbH provides global strategy consulting services. It specializes in business, customer, operations, organization, and technology strategy. The company was founded in March 2014 and is headquartered in Dusseldorf, Germany.

Barcare GmbH provides administration and management services. The company is based in Munich, Germany. Jörg Lübcke has been the CEO of the German company since 2015.

DLD Ventures GmbH (DLD Ventures) is a venture capital subsidiary of Burda Digital GmbH, itself owned by Burda family. The firm was founded in 2009 and it is headquartered in Munich, Germany.

Giesecke+Devrient GmbH engages in the development, manufacture, and distribution of products and solutions for the safeguarding of payment processes, identities, connectivity, and data. It distributes its products under the G+D, G+D Bildmarke, G+D Bildmarke, and Giesecke+Devrient brands. The company was founded by Hermann Giesecke and Alphonse Devrient on June 1, 1852 and is headquartered in Munich, Germany.

ino24 AG is engaged in the provision of insurance solutions. It specializes in the areas of private health, other insurances, and information about financial assets. It also provides daily allowance, time deposits, financing, loans, and installment credits. The company was founded in 1987 and is headquartered in Pleidelsheim, Germany.

i-potentials GmbH provides recruiting and consulting services. It offers human resources services for internet companies and startups. The firm provides recruiting and coaching services for internet companies. The company was founded by Constanze Buchheim in 2009 and is headquartered in Berlin, Germany

Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom.

Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland.

Founded in 2018, Orbit Biomedical Ltd. is a British biotechnology company that engages in research and development. Part of Novartis AG, the company is based in Stevenage, UK.

Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom.

Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom.